Erratum: Hypersensitivity pneumonitis: Perspectives in diagnosis and management (American Journal of Respiratory and Critical Care Medicine (2017) 196 (680-689) DOI: 10.1164/rccm.201611-2201PP);Hypersensitivity pneumonitis: Perspectives in diagnosis and management

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 6, 2017, Pages 680-689

  Vasakova, Martina ^a   Morell, Ferran ^b   Walsh, Simon ^c   Leslie, Kevin ^d   Raghu, Ganesh ^e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOMODULATING AGENT; ANTIGEN; ENZYME INHIBITOR; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; INDOLE DERIVATIVE; NINTEDANIB; NONSTEROID ANTIINFLAMMATORY AGENT; PIRFENIDONE; PYRIDONE DERIVATIVE;

ALLERGIC PNEUMONITIS; ANTIGEN DETECTION; BLOOD; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE COURSE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HEREDITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LUNG PARENCHYMA; LUNG TRANSPLANTATION; PHENOTYPE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; ACUTE DISEASE; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; CYTOLOGY; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; IMMUNOLOGY; LUNG; PATHOLOGY; X-RAY COMPUTED TOMOGRAPHY;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ALVEOLITIS, EXTRINSIC ALLERGIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; DISEASE PROGRESSION; ENZYME INHIBITORS; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INDOLES; LUNG; LUNG TRANSPLANTATION; PYRIDONES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85029685953     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.v199erratum4     Document Type: Erratum

References (86)

1. Ramazzini B. De morbis artificium diatriba. Modena: Antonio Capponi; 1700. pp. 360
2. Pepys J, Riddell RW, Citron KM, Clayton YM. Precipitins against extracts of hay and moulds in the serum of patients with farmer’s lung, aspergillosis, asthma, and sarcoidosis. Thorax 1962;17:366–374.
3. Morell F, Villar A, Montero MA, Muñoz X, Colby TV, Pipvath S, Cruz MJ, Raghu G. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case–cohort study. Lancet Respir Med 2013;1:685–694.
4. Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, et al.; ARTEMIS-IPF Investigators. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med 2013;158: 641–649.
5. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al.; ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083–2092.
6. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al.; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370: 2071–2082.
7. Hashimoto S, Ueyama M, Terada S, Nakanishi T, Hamao N, Inao T, Yasuda Y, Morimoto C, Okamori S, Kaji Y, et al. Patients with both possible UIP pattern on high-resolution CT and consistent with UIP pattern on histopathological criteria could include those of interstitial lung diseases with known causes rather than idiopathic pulmonary fibrosis: a retrospective analysis of 60 cases [abstract]. Am J Respir Crit Care Med 2016;193:A6214.
8. Sterclova M, Paulik M, Skibova J, Vasakova M. Inhalation antigens sensitisation in Czech hypersensitivity pneumonitis patients [abstract]. Am J Respir Crit Care Med 2016;193:A6273.
9. White ES, Borok Z, Brown KK, Eickelberg O, Guenther A, Jenkins RG, Kolb M, Martinez FJ, Roman J, Sime P; American Thoracic Society Respiratory Cell and Molecular Biology Assembly Working Group on Pulmonary Fibrosis. An American Thoracic Society official research statement: future directions in lung fibrosis research. Am J Respir Crit Care Med 2016;193:792–800.
10. Elicker BM, Jones KD, Henry TS, Collard HR. Multidisciplinary approach to hypersensitivity pneumonitis. J Thorac Imaging 2016;31:92–103.
11. Johannson KA, Elicker BM, Vittinghoff E, Assayag D, de Boer K, Golden JA, Jones KD, King TE, Koth LL, Lee JS, et al. A diagnostic model for chronic hypersensitivity pneumonitis. Thorax 2016;71:951–954.
12. Salisbury ML, Myers JL, Belloli EA, Kazerooni EA, Martinez FJ, Flaherty KR. Diagnosis and treatment of fibrotic hypersensitivity pneumonia: where we stand and where we need to go. Am J Respir Crit Care Med 2017;196:690–699.
13. Hyldgaard C, Hilberg O, Muller A, Bendstrup E. A cohort study of interstitial lung diseases in central Denmark. Respir Med 2014;108: 793–799.
14. Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, Fell CD, Manganas H, Dubé BP, Wolters PJ, et al. Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis. Chest 2017;151:619–625.
15. Kern RM, Singer JP, Koth L, Mooney J, Golden J, Hays S, Greenland J, Wolters P, Ghio E, Jones KD, et al. Lung transplantation for hypersensitivity pneumonitis. Chest 2015;147:1558–1565.
16. Wang P, Jones KD, Urisman A, Elicker BM, Urbania T, Johannson KA, Assayag D, Lee J, Wolters PJ, Collard HR, et al. Pathological findings and prognosis in a large prospective cohort of chronic hypersensitivity pneumonitis. Chest [online ahead of print] 20 Feb 2017. DOI: 10.1016/j.chest.2017.02.011.
17. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994;150: 967–972.
18. Solaymani-Dodaran M, West J, Smith C, Hubbard R. Extrinsic allergic alveolitis: incidence and mortality in the general population. QJM 2007;100:233–237.
19. Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S, Singh N, Ho L, Samaria JK, Bhattacharya P, et al. Interstitial lung disease in India: results of a prospective registry. Am J Respir Crit Care Med 2017;195:801–813.
20. Morell F, Reyes L, Doménech G, De Gracia J, Majó J, Ferrer J. [Diagnoses and diagnostic procedures in 500 consecutive patients with clinical suspicion of interstitial lung disease [in Spanish]. Arch Bronconeumol 2008;44:185–191.
21. Lacasse Y, Selman M, Costabel U, Dalphin JC, Ando M, Morell F, Erkinjuntti-Pekkanen R, Muller N, Colby TV, Schuyler M, et al.; HP Study Group. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003;168:952–958.
22. Hanak V, Golbin JM, Ryu JH. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin Proc 2007;82:812–816.
23. Fernández Pérez ER, Swigris JJ, Forssén AV, Tourin O, Solomon JJ, Huie TJ, Olson AL, Brown KK. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest 2013;144:1644–1651.
24. Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE Jr, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 2014; 145:723–728.
25. Inase N, Ohtani Y, Sumi Y, Umino T, Usui Y, Miyake S, Yoshizawa Y. A clinical study of hypersensitivity pneumonitis presumably caused by feather duvets. Ann Allergy Asthma Immunol 2006;96:98–104.
26. Jordan LE, Guy E. Paediatric feather duvet hypersensitivity pneumonitis. BMJ Case Rep 2015; DOI: 10.1136/bcr-2014-207956.
27. Richerson HB, Bernstein IL, Fink JN, Hunninghake GW, Novey HS, Reed CE, Salvaggio JE, Schuyler MR, Schwartz HJ, Stechschulte DJ. Guidelines for the clinical evaluation of hypersensitivity pneumonitis: report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol 1989;84:839–844.
28. Mooney JJ, Elicker BM, Urbania TH, Agarwal MR, Ryerson CJ, Nguyen MLT, Woodruff PG, Jones KD, Collard HR, King TE Jr, et al. Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest 2013;144:586–592.
29. Fernández Pérez ER, Brown KK. Fibrotic hypersensitivity pneumonitis. Curr Respir Care Rep 2014;3:170–178.
30. Walsh SL, Sverzellati N, Devaraj A, Wells AU, Hansell DM. Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. Eur Radiol 2012;22:1672–1679.
31. Churg A, Sin DD, Everett D, Brown K, Cool C. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol 2009;33:1765–1770.
32. Ojanguren I, Morell F, Villar A, Ramon MA, Munoz X, Cruz MJ. Mortality and survival predictors in chronic hypersensitivity pneumonitis. Presented at the ERS Congress, September 4, 2016, London, United Kingdom. Thematic poster session 175: Sarcoidosis, PA833.
33. Walsh SLF, Wells AU, Sverzellati N, Devaraj A, von der Thüsen J, Yousem SA, Colby TV, Nicholson AG, Hansell DM. Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease. BMC Med 2015;13:241.
34. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64:401–406.
35. Reich JM. Chirping rales in bird-fancier’s lung. Chest 1993;104: 326–327.
36. Lacasse Y, Girard M, Cormier Y. Recent advances in hypersensitivity pneumonitis. Chest 2012;142:208–217.
37. Lynch DA, Rose CS, Way D, King TE Jr. Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. AJR Am J Roentgenol 1992;159:469–472.
38. Adler BD, Padley SP, Müller NL, Remy-Jardin M, Remy J. Chronic hypersensitivity pneumonitis: high-resolution CT and radiographic features in 16 patients. Radiology 1992;185:91–95.
39. Lynch DA, Newell JD, Logan PM, King TE Jr, Müller NL. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol 1995;165:807–811.
40. Silva CI, Müller NL, Lynch DA, Curran-Everett D, Brown KK, Lee KS, Chung MP, Churg A. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008;246: 288–297.
41. Remy-Jardin M, Remy J, Wallaert B, Müller NL. Subacute and chronic bird breeder hypersensitivity pneumonitis: sequential evaluation with CT and correlation with lung function tests and bronchoalveolar lavage. Radiology 1993;189:111–118.
42. Buschman DL, Gamsu G, Waldron JA Jr, Klein JS, King TE Jr. Chronic hypersensitivity pneumonitis: use of CT in diagnosis. Am J Roentgenol 1992;159: 957–960.
43. Hansell DM, Wells AU, Padley SP, Müller NL. Hypersensitivity pneumonitis: correlation of individual CT patterns with functional abnormalities. Radiology 1996;199:123–128.
44. Lalancette M, Carrier G, Laviolette M, Ferland S, Rodrique J, Bégin R, Cantin A, Cormier Y. Farmer’s lung: long-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors. Am Rev Respir Dis 1993;148:216–221.
45. Cormier Y, Brown M, Worthy S, Racine G, Müller NL. High-resolution computed tomographic characteristics in acute farmer’s lung and in its follow-up. Eur Respir J 2000;16:56–60.
46. Erkinjuntti-Pekkanen R, Rytkonen H, Kokkarinen JI, Tukiainen HO, Partanen K, Terho EO. Long-term risk of emphysema in patients with farmer’s lung and matched control farmers. Am J Respir Crit Care Med 1998;158:662–665.
47. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, et al.; American Thoracic Society Committee on BAL in Interstitial Lung Disease. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012;185:1004–1014.
48. Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Muñoz X. Bird fancier’s lung: a series of 86 patients. Medicine (Baltimore) 2008;87:110–130.
49. Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179:1043–1047.
50. Caillaud DM, Vergnon JM, Madroszyk A, Melloni BM, Murris M, Dalphin JC; French Group of Environmental Immunoallergic Bronchopulmonary Diseases. Bronchoalveolar lavage in hypersensitivity pneumonitis: a series of 139 patients. Inflamm Allergy Drug Targets 2012;11:15–19.
51. Ohtani Y, Saiki S, Kitaichi M, Usui Y, Inase N, Costabel U, Yoshizawa Y. Chronic bird fancier’s lung: histopathological and clinical correlation: an application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005;60:665–671.
52. Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, et al. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J 2015;46:186–196.
53. Costabel U, Bonella F, Guzman J. Chronic hypersensitivity pneumonitis. Clin Chest Med 2012;33:151–163.
54. Millerick-May ML, Mulks MH, Gerlach J, Flaherty KR, Schmidt SL, Martinez FJ, LeVeque RM, Rosenman KD. Hypersensitivity pneumonitis and antigen identification—an alternate approach. Respir Med 2016;112:97–105.
55. Van Hoeyveld E, Dupont L, Bossuyt X. Quantification of IgG antibodies to Aspergillus fumigatus and pigeon antigens by ImmunoCAP technology: an alternative to the precipitation technique? Clin Chem 2006;52:1785–1793.
56. Rodrigo MJ, Benavent MI, Cruz MJ, Rosell M, Murio C, Pascual C, Morell F. Detection of specific antibodies to pigeon serum and bloom antigens by enzyme linked immunosorbent assay in pigeon breeder’s disease. Occup Environ Med 2000;57:159–164.
57. Morell F, Roger A, Cruz MJ, Muñoz X, Rodrigo MJ. Suberosis: clinical study and new etiologic agents in a series of eight patients. Chest 2003;124:1145–1152.
58. Millon L, Reboux G, Barrera C, Rognon B, Roussel S, Monod M. Immunoproteomics for serological diagnosis of hypersensitivity pneumonitis caused by environmental microorganisms. Curr Protein Pept Sci 2014;15:430–436.
59. Suhara K, Miyazaki Y, Okamoto T, Yasui M, Tsuchiya K, Inase N. Utility of immunological tests for bird-related hypersensitivity pneumonitis. Respir Investig 2015;53:13–21.
60. Fenoglio CM, Reboux G, Sudre B, Mercier M, Roussel S, Cordier JF, Piarroux R, Dalphin JC. Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis. Eur Respir J 2007;29:706–712.
61. Muñoz X, Sánchez-Ortiz M, Torres F, Villar A, Morell F, Cruz M-J. Diagnostic yield of specific inhalation challenge in hypersensitivity pneumonitis. Eur Respir J 2014;44:1658–1665.
62. Morell F, Orriols R, Antó JM, Bernadó Ll, Bofill JM. El pulmón del cuidador de aves: estudio clínico de 25 casos. Arch Bronconeumol 1985;21:109–117.
63. Morell F, Villar A, Ojanguren I, Muñoz X, Cruz MJ. Hypersensitivity pneumonitis: challenges in diagnosis and management, avoiding surgical lung biopsy. Semin Respir Crit Care Med 2016;37:395–405.
64. Myers JL. Hypersensitivity pneumonia: the role of lung biopsy in diagnosis and management. Mod Pathol 2012;25:S58–S67.
65. Tomassetti S, Wells AU, Costabel U, Cavazza A, Colby TV, Rossi G, Sverzellati N, Carloni A, Carretta E, Buccioli M, et al. Bronchoscopic lung cryobiopsy increases diagnostic confidence in multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2016;193:745–752.
66. Casoni GL, Tomassetti S, Cavazza A, Colby TV, Dubini A, Ryu JH, Carretta E, Tantalocco P, Piciucchi S, Ravaglia C, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One 2014;9:e86716.
67. Pajares V, Puzo C, Castillo D, Lerma E, Montero MA, Ramos-Barbón D, Amor-Carro O, Gil de Bernabé A, Franquet T, Plaza V, et al. Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology 2014;19:900–906.
68. Johannson KA, Marcoux VS, Ronksley PE, Ryerson CJ. Diagnostic yield and complications of transbronchial lung cryobiopsy for interstitial lung disease: a systematic review and metaanalysis. Ann Am Thorac Soc 2016;13:1828–1838.
69. Sharp C, McCabe M, Adamali H, Medford AR. Use of transbronchial cryobiopsy in the diagnosis of interstitial lung disease—a systematic review and cost analysis. QJM 2017;110:207–214.
70. Iftikhar IH, Alghothani L, Sardi A, Berkowitz D, Musani AI. Transbronchial lung cryobiopsy and video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse parenchymal lung disease: a meta-analysis of diagnostic test accuracy. Ann Am Thorac Soc 2017;14:1197–1211.
71. Gershman E, Fruchter O, Benjamin F, Nader AR, Rosengarten D, Rusanov V, Fridel L, Kramer MR. Safety of cryo-transbronchial biopsy in diffuse lung diseases: analysis of three hundred cases. Respiration 2015;90:40–46.
72. Takemura T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y. Pathology of hypersensitivity pneumonitis. Curr Opin Pulm Med 2008;14:440–454.
73. Churg A, Muller NL, Flint J, Wright JL. Chronic hypersensitivity pneumonitis. Am J Surg Pathol 2006;30:201–208.
74. Smith M, Dalurzo M, Panse P, Parish J, Leslie K. Usual interstitial pneumonia-pattern fibrosis in surgical lung biopsies: clinical, radiological and histopathological clues to aetiology. J Clin Pathol 2013;66:896–903.
75. Faruqi S, Thompson R, Wright C, Sheedy W, Morice AH. Quantifying chronic cough: objective versus subjective measurements. Respirology 2011;16:314–320.
76. Kokkarinen JI, Tukiainen HO, Terho EO. Effect of corticosteroid treatment on the recovery of pulmonary function in farmer’s lung. Am Rev Respir Dis 1992;145:3–5.
77. Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ; Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968–1977.
78. Lota HK, Keir GJ, Hansell DM, Nicholson AG, Maher TM, Wells AU, Renzoni EA. Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment. Thorax 2013;68:780–781.
79. Morell F, Jeanneret A, Aïache JM, Molina C. Leukocyte migration inhibition in farmer’s lung. J Allergy Clin Immunol 1982;69: 405–409.
80. Morell F, Curull V, Orriols R, De Gracia J. Skin tests in bird breeder’s disease. Thorax 1986;41:538–541.
81. Okamoto T, Fujii M, Furusawa H, Tsuchiya K, Miyazaki Y, Inase N. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis. Respir Med 2015;109: 1576–1581.
82. Vasakova M, Sterclova M, Kolesar L, Slavcev A, Pohunek P, Sulc J, Skibova J, Striz I. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Scand J Immunol 2009;69: 268–274.
83. Long X, He X, Ohshimo S, Griese M, Sarria R, Guzman J, Costabel U, Bonella F. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis. Eur Respir J 2017 49:1501924.
84. Reghellin D, Poletti V, Tomassett S, Dubini A, Cavazza A, Rossi G, Lestani M, Pedron S, Daniele I, Montagna L, et al. Cathepsin-K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis 2010;27:57–63.
85. Selman M, Pardo A, Barrera L, Estrada A, Watson SR, Wilson K, Aziz N, Kaminski N, Zlotnik A. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006;173:188–198.
86. Camarena A, Juárez A, Mejía M, Estrada A, Carrillo G, Falfán R, Zuñiga J, Navarro C, Granados J, Selman M. Major histocompatibility complex and tumor necrosis factor-a polymorphisms in pigeon breeder’s disease. Am J Respir Crit Care Med 2001;163:1528–1533.